1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Defibrillator Market – By Product

1.3.2        North America Defibrillator Market – By End User

1.3.3        North America Defibrillator Market – By Country

2.           North America Defibrillator Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Defibrillator Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Experts Opinion

5.           North America Defibrillator Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cardiovascular Diseases

5.1.2        Rising Training and Awareness Programs on Cardiopulmonary Resuscitation and Automated External Defibrillators

5.2         Market Restraints

5.2.1        Cost and Performance Issues Related to Implantable and Automated External Defibrillators

5.3         Market Opportunities

5.3.1        Strategies by Major Market Players to Expand Presence

5.4         Future Trends

5.4.1        Technological Advancements

5.5         Impact Analysis

6.           Defibrillator Market– North America Analysis

6.1         North America Defibrillator Market Revenue Forecast and Analysis

7.           North America Defibrillator Market– by Product

7.1         Overview

7.2         North America Defibrillator Market, By Product, 2021 & 2028 (%)

7.3         Implantable Cardioverter Defibrillator

7.3.1        Overview

7.3.2        Implantable Cardioverter: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3        Transvenous ICD

7.3.3.1          Overview

7.3.3.2          Transvenous ICD: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4        Subcutaneous ICD

7.3.4.1          Overview

7.3.4.2          Subcutaneous ICD: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

7.4         External

7.4.1        Overview

7.4.2        External: North America Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Manual

7.4.3.1          Overview

7.4.3.2          Manual: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        Fully Automated External Defibrillators

7.4.4.1          Overview

7.4.4.2          Fully Automated External: North America Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        Wearable

7.4.5.1          Overview

7.4.5.2          Wearable: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

8.           North America Defibrillator Market– by End User

8.1         Overview

8.2         North America Defibrillator Market Share by End User - 2021 & 2028 (%)

8.3         Hospitals and Clinics

8.3.1        Overview

8.3.2        Hospitals and Clinics: North America Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Prehospital Care

8.4.1        Overview

8.4.2        Prehospital Care: North America Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Public Access

8.5.1        Overview

8.5.2        Public Access: North America Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Home Care Settings

8.6.1        Overview

8.6.2        Home Care Settings: North America Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)

8.7         Alternate Care Facilities

8.7.1        Overview

8.7.2        Alternate Care Facilities: North America Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)

9.           North America Defibrillator Market– Country Analysis

9.1         North America: Defibrillator Market

9.1.1        Overview

9.1.2        North America: Defibrillator Market, by Country, 2021 & 2028 (%)

9.1.2.1          US: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.1          Overview

9.1.2.1.2          US: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.3          US: Defibrillator Market, by Product, 2019–2028 (US$ Million)

9.1.2.1.3.1        US: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)

9.1.2.1.3.2        US: Defibrillator Market, by External, 2019–2028 (US$ Million)

9.1.2.1.4          US: Defibrillator Market, by End User, 2019–2028 (US$ Million)

9.1.2.2          Canada: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.1          Overview

9.1.2.2.2          Canada: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.3          Canada: Defibrillator Market, by Product, 2019–2028 (US$ Million)

9.1.2.2.3.1        Canada: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)

9.1.2.2.3.2        Canada: Defibrillator Market, by External, 2019–2028 (US$ Million)

9.1.2.2.4          Canada: Defibrillator Market, by End User, 2019–2028 (US$ Million)

9.1.2.3          Mexico: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.1          Overview

9.1.2.3.2          Mexico: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.3          Mexico: Defibrillator Market, by Product, 2019–2028 (US$ Million)

9.1.2.3.3.1        Mexico: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)

9.1.2.3.3.2        Mexico: Defibrillator Market, by External, 2019–2028 (US$ Million)

9.1.2.3.4          Mexico: Defibrillator Market, by End User, 2019–2028 (US$ Million)

10.        Impact Of COVID-19 Pandemic on North America Defibrillator Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Medtronic

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Boston Scientific Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Koninklijke Philips N.V.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Biotronik, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      ZOLL MEDICAL CORPORATION

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Nihon Kohden Corporation

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Shenzhen Mindray Biomedical Electronics Co., Ltd.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Defibrillator Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Defibrillator Market, by External– Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Defibrillator Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Defibrillator Market, by External– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico: Defibrillator Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Defibrillator Market, by External– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments Done By Companies

Table 15.          Inorganic Developments Done By Companies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Defibrillator Market Segmentation

Figure 2.           North America Defibrillator Market Segmentation, By Country

Figure 3.           North America Defibrillator Market Overview

Figure 4.           Implantable Cardioverter Defibrillator (ICD) Held the Largest Share of the Product Segment in North America Defibrillator Market

Figure 5.           US to Show Significant Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Defibrillator Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Defibrillator Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           North America Defibrillator Market, by Product, 2021 & 2028 (%)

Figure 10.        Implantable Cardioverter: North America Defibrillator: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Transvenous ICD: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Subcutaneous ICD: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        External: North America Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Manual: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Fully Automated External: North America Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Wearable: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        North America Defibrillator Market Share by End User - 2021 & 2028 (%)

Figure 18.        Hospitals and Clinics: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Prehospital Care: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Public Access: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Home Care Settings: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Alternate Care Facilities: North America Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        North America: Defibrillator Market, by Key Country – Revenue (2021) (US$ Million)

Figure 24.        North America: Defibrillator Market, by Country, 2021 & 2028 (%)

Figure 25.        US: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Canada: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Mexico: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Impact of COVID-19 Pandemic in North American Country Markets